Literature DB >> 12874783

Aneuploidy in oncocytic lesions of the thyroid gland: diffuse accumulation of mitochondria within the cell is associated with trisomy 7 and progressive numerical chromosomal alterations.

Tinuccia Dettori1, Daniela V Frau, Maria L Lai, Stefano Mariotti, Alessandro Uccheddu, Giovanni M Daniele, Giovanni Tallini, Gavino Faa, Roberta Vanni.   

Abstract

Oncocytic cells are characterized by a greatly increased number of mitochondria that distend the cell cytoplasm and result in a distinctive granular appearance of the cell on conventional histology sections. Oncocytes are frequently found in metabolically active human tissues including the thyroid gland, and, as a general rule, when their proportion in a thyroid tumor is greater than 75% the tumor is referred to as oncocytic (Hürthle cell) adenoma or carcinoma. Such tumors represent a subset of thyroid lesions, and recently, both interphase fluorescence in situ hybridization (FISH) and comparative genomic hybridization (CGH) studies reported that they may show aneuploidy, with widespread numerical chromosomal alterations. In contrast, very few cases have been studied by conventional cytogenetic analysis. Whether the cells with chromosomal changes are the same as those with mitochondrial accumulation or whether lesions only partially composed of oncocytic cells also have cytogenetic alterations is unclear. To investigate the relationship between acquisition of the oncocytic phenotype and numerical chromosomal changes, we analyzed a random selection of thyroid lesions with (18 cases) and without (11 cases) morphological evidence of oncocytic differentiation. Lesions with oncocytes included hyperplastic nodules, adenomas, Hürthle cell tumors, and papillary carcinomas with lymphocytic stroma (Whartin-like tumors of the thyroid). Karyotypic changes were analyzed by cytogenetic analysis, FISH, or CGH, and the results were compared with in situ analysis of mitochondrial accumulation by immunofluorescence. A striking correlation between the presence of oncocytes and the presence of aneuploid katyotypes was seen in the oncocytic follicular thyroid nodules, but not in the oncocytic papillary tumors. Structural chromosome changes or normal karyotypes were observed in the lesions lacking oncocytic features. Extending the FICTION technique to the evaluation of a cytoplasmic antigen (mitochondrial membrane antigen), we pursued the simultaneous visualization of both mitochondrial increase and numerical chromosomal alterations, and showed that oncocytes of follicular lesions are prone to become aneuploid. Our data support the contention that follicular tumors composed of oncocytes should be regarded as a distinct subset. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2003        PMID: 12874783     DOI: 10.1002/gcc.10238

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  8 in total

Review 1.  Hurthle Cell Lesion: Controversies, Challenges, and Debates.

Authors:  Michael Shawky; Mahmoud Sakr
Journal:  Indian J Surg       Date:  2015-10-30       Impact factor: 0.656

2.  DNA copy number variations characterize benign and malignant thyroid tumors.

Authors:  Yan Liu; Leslie Cope; Wenyue Sun; Yongchun Wang; Nijaguna Prasad; Lauren Sangenario; Kristen Talbot; Helina Somervell; William Westra; Justin Bishop; Joseph Califano; Martha Zeiger; Christopher Umbricht
Journal:  J Clin Endocrinol Metab       Date:  2013-01-23       Impact factor: 5.958

3.  Phenotypic and genetic characterization of circulating tumor cells by combining immunomagnetic selection and FICTION techniques.

Authors:  María Campos; Celia Prior; Fernando Warleta; Isabel Zudaire; Jesús Ruíz-Mora; Raúl Catena; Alfonso Calvo; José J Gaforio
Journal:  J Histochem Cytochem       Date:  2008-04-14       Impact factor: 2.479

Review 4.  Molecular Alterations in Thyroid Carcinoma.

Authors:  Mohamed Rizwan Haroon Al Rasheed; Bin Xu
Journal:  Surg Pathol Clin       Date:  2019-09-27

5.  Genome haploidisation with chromosome 7 retention in oncocytic follicular thyroid carcinoma.

Authors:  Willem E Corver; Dina Ruano; Karin Weijers; Wietske C E den Hartog; Merlijn P van Nieuwenhuizen; Noel de Miranda; Ronald van Eijk; Anneke Middeldorp; Ekaterina S Jordanova; Jan Oosting; Ellen Kapiteijn; Guido Hovens; Jan Smit; Tom van Wezel; Hans Morreau
Journal:  PLoS One       Date:  2012-06-01       Impact factor: 3.240

6.  Point mutation in GRIM-19: a new genetic lesion in Hurthle cell thyroid carcinomas.

Authors:  A Fusco; G Viglietto; M Santoro
Journal:  Br J Cancer       Date:  2005-05-23       Impact factor: 7.640

7.  A mutation screening of oncogenes, tumor suppressor gene TP53 and nuclear encoded mitochondrial complex I genes in oncocytic thyroid tumors.

Authors:  Cecilia Evangelisti; Dario de Biase; Ivana Kurelac; Claudio Ceccarelli; Holger Prokisch; Thomas Meitinger; Paola Caria; Roberta Vanni; Giovanni Romeo; Giovanni Tallini; Giuseppe Gasparre; Elena Bonora
Journal:  BMC Cancer       Date:  2015-03-21       Impact factor: 4.430

8.  RAC1 Alterations Induce Acquired Dabrafenib Resistance in Association with Anaplastic Transformation in a Papillary Thyroid Cancer Patient.

Authors:  Rozita Bagheri-Yarmand; Naifa L Busaidy; Elena McBeath; Brian P Danysh; Kurt W Evans; Tyler J Moss; Argun Akcakanat; Patrick K S Ng; Christina M Knippler; Jalyn A Golden; Michelle D Williams; Asha S Multani; Maria E Cabanillas; Kenna R Shaw; Funda Meric-Bernstam; Manisha H Shah; Matthew D Ringel; Marie Claude Hofmann
Journal:  Cancers (Basel)       Date:  2021-09-30       Impact factor: 6.575

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.